Top Markets
Coin of the day
ContextVision AB (publ) ContextVision AB (publ)

ContextVision AB (publ)

0L8Z
Rangering i aksjer #27954
ContextVision AB (publ), a Swedish medical technology company established in... ContextVision AB (publ), a Swedish medical technology company established in 1983 and headquartered in Stockholm, develops sophisticated image analysis and artificial intelligence software. These solutions are supplied to original equipment manufacturers (OEMs) across Asia, Europe, and the United States. The firm specializes in enhancing image quality for various medical imaging technologies, including 2D/3D/4D ultrasound, radiography, magnetic resonance imaging (MRI), and mammography. Key products in their lineup include Rivent, which delivers exceptional image clarity for diverse ultrasound applications such as women's health, general imaging, cardiovascular, and point-of-care. They also offer VolarView for improved visuals in handheld ultrasound devices, and GOPiCE, providing real-time volumetric image enhancement. Furthermore, ContextVision provides Altumira/Altumira Plus, a dedicated platform for digital radiography, alongside an Orthopedic Package for skeletal imaging. Their offerings extend to GOPView MRI2Plus for advanced MRI image refinement and INIFY Prostate Screening, a tool for the digital analysis of prostate biopsies.
Aksjekurs
$0.39098275
Sist synkronisert: 2026-02-11
Markedsverdi
$29.58M
Endring (1 dag)
0.01%
Endring (1 år)
-12.48%
Land
SE
Handel ContextVision AB (publ) (0L8Z)

Kategori

Aksjeprishistorikk for ContextVision AB (publ) (0L8Z)
Høyeste sluttskurs: $0.39 den 2026-02-01

Laveste sluttskurs: $0.75 den 2017-03-01
Aksjeprishistorikk for ContextVision AB (publ) fra 2017 til 2026
Årlig aksjeprisytelse
År Ytelse
2026 (TTM) -0.83%
2025 -18.06%
2024 -33.55%
2023 -21.96%
2022 -53.41%
2021 -4.17%
2020 217.00%
2018 -5.08%
2017 0.00%
Aksjepris for lignende selskaper eller konkurrenter
Selskap Aksjepris Endring 1år% Land
$220.51 -19.05%
DE
$148.59 8.24%
CA
$206.02 -16.41%
US
$77.97 -16.82%
US
$127.32 -28.49%
US